Fig. 2From: Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemiaAutophagosomes accumulation was induced by PARP inhibitor talazoparib in CML cells. Ultrastructural analysis of P#1 cells (a) and P#2 cells (b) treated with 20 μM of talazoparib for 48 h by TEM. The relative number of autophagosomes were quantified by Image J software (N = 3, mean ± SD, **P < 0.01)Back to article page